Assessing the acceptability, affordability, and availability of teleoncology services among cancer patients: A cross-sectional study
- PMID: 40814462
- PMCID: PMC12349859
- DOI: 10.4103/jfmpc.jfmpc_341_25
Assessing the acceptability, affordability, and availability of teleoncology services among cancer patients: A cross-sectional study
Abstract
Context: With the increasing burden of cancer and the need for continuous patient monitoring, teleoncology has emerged as an innovative approach to improve healthcare delivery. However, its utilization in real-world settings, particularly in resource-limited regions, remains underexplored.
Aims: This study aims to assess cancer patients' perceptions of teleoncology services, focusing on their acceptability, affordability, and accessibility.
Settings and design: A cross-sectional hospital-based study was carried out in Jaipur, Rajasthan.
Methods and material: This study was conducted from July 2024 to December 2024 using a semistructured questionnaire. Cancer patients utilizing teleoncology services for consultations, follow-ups, and disease monitoring were included. The Service User Technology Acceptability Questionnaire (SUTAQ) was used to measure acceptability. Data were analyzed for demographic variations and affordability perceptions.
Statistical analysis used: Collected data were analyzed (Descriptive and Inferential) using SPSS V.25.
Results: A total of 125 patients participated in the study, with a nearly equal gender distribution (50.79% male, 49.21% female). The mean age of male and female respondents was 48.27 ± 14.53 years and 43.17 ± 14.39 years, respectively. Acceptability: 77% of patients reported using teleoncology not just for cancer care but also for other health conditions. The mean satisfaction score was 4.2, indicating high acceptance. Affordability: There was no significant difference in perceptions of affordability across gender, geography, or age groups (P > 0.05). Patients found teleoncology cost-effective, with a mean affordability perception of 4.3 (agree to strongly agree). Availability: While 48.1% agreed that services were available 24/7, 38.4% disagreed, indicating gaps in accessibility. Specialist availability received a mean score of 3.6, reflecting moderate satisfaction.
Conclusions: Teleoncology is widely accepted due to its convenience and affordability, but challenges remain regarding 24/7 service availability and digital literacy. A hybrid model integrating teleoncology with periodic in-person visits could enhance patient experience. Imminent research should focus on long-term outcomes and strategies to improve teleoncology adoption among underserved populations.
Keywords: Acceptability; accessibility; affordability; availability; cancer; teleoncology.
Copyright: © 2025 Journal of Family Medicine and Primary Care.
Conflict of interest statement
There are no conflicts of interest.
Figures
Similar articles
-
Prescription of Controlled Substances: Benefits and Risks.2025 Jul 6. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2025 Jul 6. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 30726003 Free Books & Documents.
-
Home treatment for mental health problems: a systematic review.Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150. Health Technol Assess. 2001. PMID: 11532236
-
Comparison of self-administered survey questionnaire responses collected using mobile apps versus other methods.Cochrane Database Syst Rev. 2015 Jul 27;2015(7):MR000042. doi: 10.1002/14651858.MR000042.pub2. Cochrane Database Syst Rev. 2015. PMID: 26212714 Free PMC article.
-
[Volume and health outcomes: evidence from systematic reviews and from evaluation of Italian hospital data].Epidemiol Prev. 2013 Mar-Jun;37(2-3 Suppl 2):1-100. Epidemiol Prev. 2013. PMID: 23851286 Italian.
-
Technology-enabled CONTACT tracing in care homes in the COVID-19 pandemic: the CONTACT non-randomised mixed-methods feasibility study.Health Technol Assess. 2025 May;29(24):1-24. doi: 10.3310/UHDN6497. Health Technol Assess. 2025. PMID: 40350743 Free PMC article.
References
-
- World Health Organization. Noncommunicable diseases. 2024. [[Last accessed on 2025 Feb]]. Available from: https://www.who.int/news-room/ fact-sheets/detail/noncommunicable-diseases .
-
- World Health Organization. Cancer. Geneva: World Health Organization; [[Last accessed on 2025 Feb]]. Available from: https://www.who. int/health-topics/cancer#tab=tab_1 .
-
- Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229–63. - PubMed
LinkOut - more resources
Full Text Sources